Quick Answer
Sonoma Pharmaceuticals, Inc. reported Total Assets of $13.69 million for fiscal year 2025.
Sonoma Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $13.69M | -7.1% |
| 2024 | $14.74M | -9.2% |
| 2023 | $16.23M | -13.9% |
| 2022 | $18.84M | +25.7% |
| 2021 | $14.99M | +2.9% |
| 2020 | $14.56M | +0.8% |
| 2019 | $14.45M | -24.8% |
| 2018 | $19.21M | -24.6% |
| 2017 | $25.46M | +84.4% |
| 2016 | $13.80M | -8.3% |
| 2015 | $15.05M | -27.6% |
| 2014 | $20.79M | +65.5% |
| 2013 | $12.56M | +60.3% |
| 2012 | $7.84M | -9.5% |
| 2011 | $8.66M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $13.62M | -0.3% | -1.7% |
| September 30, 2025 | $13.86M | +1.2% | -5.1% |
| June 30, 2025 | $14.59M | +6.7% | +6.6% |
| March 31, 2025 | $13.69M | -7.1% | +0.2% |
| December 31, 2024 | $13.67M | -6.5% | -0.1% |
| September 30, 2024 | $13.69M | +0.4% | +0.1% |
| June 30, 2024 | $13.67M | -14.0% | -7.2% |
| March 31, 2024 | $14.74M | -9.2% | +0.8% |
- Sonoma Pharmaceuticals, Inc. showed a decrease of -7.1% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Sonoma Pharmaceuticals, Inc.’s total assets has grown by 58.0% (from $8.66 million to $13.69 million).
- The most recent figure is from Sonoma Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: